Logo

UT Southwestern Using WaferGen's SmartChip in Wound Care Studies

Jan 08, 2009
NEW YORK (GenomeWeb News) — The University of Texas Southwestern Medical Center will use WaferGen’s real-time PCR system in its gene expression biomarker research, the company said today.
 
Under the collaborative agreement, UT Southwestern will use the company’s SmartChip system to identify and validate biomarkers related to wound healing, and it will study the impact of those biomarkers on patient response to treatment.
 
The research may lead to discovery of specific genes related to wound healing that could be used to develop new tools for determining appropriate treatments, said Fremont, Calif.-based WaferGen.
 
Financial terms of the agreement were not released.

Filed under

Diagnostics
Microarrays & Multiplexing
microarrays
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.